A Study to Assess the Pharmacokinetics and Food Effect of SR419 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 2, 2021

Primary Completion Date

March 12, 2021

Study Completion Date

March 12, 2021

Conditions

Healthy

Interventions

DRUG

SR419

2 formulations of SR419, SR419 suspension and SR419 capsule will be used in the study.

Trial Locations (1)

CMAX Clinical Research, Adelaide

All Listed Sponsors

lead

SIMR (Australia) Biotech Pty Ltd.

INDUSTRY

NCT04705077 - A Study to Assess the Pharmacokinetics and Food Effect of SR419 in Healthy Subjects | Biotech Hunter | Biotech Hunter